BioSpace News Archive

Business

Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022

Paragon 28, Inc. today announced a range of its preliminary unaudited revenue for the fourth quarter and full-year ended December 31, 2022.

January 10, 2023
·
3 min read
Business

GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook

GE HealthCare, a leader in precision care innovation, announced preliminary unaudited revenue results for the fourth quarter and full year 2022.

January 10, 2023
·
10 min read
FDA

EndoTheia Inc. Announces FDA Breakthrough Device Designation for Technology to Improve Endoscopic Surgery

EndoTheia Inc.announced today that it has gained priority status from the FDA by receiving a Breakthrough Device designation from the agency for its technology that radically improves minimally invasive flexible endoscopic surgery.

January 10, 2023
·
3 min read
Business

Amarin Board of Directors Announces Appointment of Murray W. Stewart, DM FRCP

Amarin Corporation plc announced that Murray W. Stewart, D.M., F.R.C.P., has been appointed to the Company’s Board of Directors.

January 10, 2023
·
4 min read
FDA

Arthrex Receives FDA Clearance for TightRope® Implant as First, Only Device Cleared for Pediatric ACL Surgery

Arthrex announced today its ACL TightRope implant has received clearance from the U.S. Food and Drug Administration (FDA) for pediatric indications.

January 10, 2023
·
4 min read
Genetown

Kymera Therapeutics Shares Key 2023 Goals to Support its Evolution into a Fully Integrated Degrader Medicines Company

Kymera Therapeutics, Inc. today announced its research, development and corporate goals for 2023.

January 10, 2023
·
12 min read
Business

Vizgen Appoints Paul Rasmussen to Spearhead Recent Expansion of MERSCOPE™ in APAC Region

Vizgen today announced the appointment of industry veteran Paul Rasmussen as Regional Vice President, Asia Pacific and Japan.

January 10, 2023
·
2 min read
Business

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2022 Revenue Results

Apyx Medical Corporation today reported preliminary revenue results for the fourth quarter and full year ended December 31, 2022.

January 10, 2023
·
6 min read
Business

Forge Biologics and Oculogenex Announce AAV Contract Development and Manufacturing Partnership

Oculogenex and Forge Biologics today announced a manufacturing partnership to help support the advancement of Oculogenex’s gene therapy program for dry age-related macular degeneration (AMD) toward clinical trials.

January 10, 2023
·
4 min read
Can-Fite Submits Market Registration Plan to European Medicines Agency for Piclidenoson in the Treatment of Psoriasis; FDA Submission to Follow

Can-Fite BioPharma Ltd. announced today it has submitted a market registration plan to the European Medicines Agency (EMA) for its lead drug candidate Piclidenoson in the treatment of moderate to severe psoriasis.

January 10, 2023
·
7 min read